Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer’s Disease

Written By Yiran Gan

2017.01.18

N. C. Lee, S. Y. Yang, J. J. Chieh, P. T. Huang, L. M. Chang,  Y. N. Chiu, A. C. Huang, Y. H. Chien, W. L. Hwu, M. J. Chiu "Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer’s Disease" Front. Aging Neurosci., 17 (2017).

http://journal.frontiersin.org/article/10.3389/fnagi.2016.00316/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Aging_Neuroscience&id=231161

Yiran Gan
Previous

Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Next

Cellular uptake of magnetite nanoparticles enhanced by NdFeB magnets in staggered arrangement